Barosense bags $27M for obesity treatment
Barosense, maker of a device to treat obesity without invasive surgery, has brought in $27 million of a targeted $30 million fourth round of funding that it plans to use to commercialize its product, reports PE Hub. It kicked off the round in March, and… Continue Reading
Cardiac monitor maker iRhythm looks to insiders for $6.5M
iRhythm Technologies, maker of a recently-launched cardiac monitoring device, has raised an additional $6.5 million in a first round of funding from existing investors, bringing the two-year-old round’s total to $19 million. Based in San Francisco, the company will use the money to more widely… Continue Reading
Barosense looks to raise $30M to market obesity device
Barosense, creator of a minimally-invasive device that can treat obesity, has announced its intent to raise $30 million in a fourth round of funding to commercialize its product. Already many of its existing investors have pledged to provide half that amount, including Delphi Ventures, Frazier… Continue Reading
Life sciences briefing: Thursday, Jan. 17, 2007
TODAY’S HEADLINES:
TransEnterix gets $21M for minimally invasive GI surgery (release)
Stem-cell developer Bioheart’s IPO postponed (Forbes.com)
Medical-practice software provider AdvancedMD acquired by Francisco Partners (release)
Peptimmune draws $8.2M for MS drug trials (release)
Drug-delivery co. Talima Thera names Martin Babler CEO (release)
Alimera Sciences aims for autumn IPO to fund… Continue Reading
Secretive Oraya raises more funds for eye devices
Oraya, a secretive Menlo Park, Calif., medical-device startup, has struck again. The company raised $18 million in what is presumably a second funding round, VentureWire reports (subscription required). Investors included Synergy Life Science Partners (see yesterday’s coverage of this newish VC firm here) and Essex… Continue Reading
IRhythm, cardiac monitoring device co., raises $12.5M
IRhythm Technologies, a secretive San Francisco start-up (no Web site) developing a cardiac-rhythm monitoring device, has raised $12.5 million in a first round of venture capital, according to PEHub.
Investos are Mohr Davidow Ventures and Synergy Life Science Partners. Company management includes Stanford fellow Uday Kumar… Continue Reading
InnerPulse, abnormal heart rhythms treatment co., raises $50M
InnerPulse, a North Carolina company developing treatments for abnormal heart rhythms, said it has raised $50 million in new equity financing.
The syndicate of investors included Johnson & Johnson Development Corporation, Medtronic, Inc., Synergy Life Science Partners, Ascent Biomedical Ventures, Delphi Ventures and Frazier Heathcare… Continue Reading
Delphi and Frazier to sell stake in life-sciences incubator, Synecor
Delphi Ventures and Frazier Healthcare Ventures are selling the minority stake they own in medical-device incubator company Synecor LLC to venture capital firms Ascent Biomedical Ventures and Synergy Life Science Partners, according to VentrueWire (sub required). The transaction has not been finalized yet.
Delphi and Frazier… Continue Reading